Aesthetic cardiology: Adipose-derived stem cells for myocardial repair

Current Stem Cell Research and Therapy

Volumn 5, Issue 2, 2010, Pages 145-152

  Palpant, Nathan J ^a   Metzger, Joseph M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adipose tissue; Cardiac; Cell regeneration; Heart failure

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; MYOCARDIN; SOMATOMEDIN; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ARTICLE; BLOOD; BONE MARROW; CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL POPULATION; CELL REGENERATION; CELL THERAPY; CORRELATION ANALYSIS; CYTOLOGY; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; LIPOSUCTION; MESENCHYMAL STEM CELL; MESODERM; METABOLIC SYNDROME X; METHODOLOGY; MORBIDITY; MORTALITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SITTING; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ADIPOSE TISSUE; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL LINEAGE; CELL TRANSDIFFERENTIATION; HEART DISEASES; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATHOLOGY; STEM CELL NICHE; TISSUE ENGINEERING;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSDIFFERENTIATION; GUIDED TISSUE REGENERATION; HEART DISEASES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL NICHE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 77954046318     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810791268654     Document Type: Article

References (120)

1. Housman TS, Lawrence N, Mellen BG, et al. The safety of liposuc-tion: results of a national survey. Dermatol Surg 2002; 28: 971-8.
2. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from humanadipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7: 211-28.
3. Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Concisereview: mesenchymal stromal cells: potential for cardiovascular re-pair. Stem Cells 2008; 26: 2201-10.
4. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiationof adipose tissue-derived stem cells. Keio J Med 2005; 54: 132-41.
5. Safford KA, Rice HE. Stem cell therapy for neurologic disorders:Therapeutic potential of adipose-derived stem cells. Curr DrugTargets 2005; 6: 57-62.
6. Bai X, Pinkernell K, Song YH, Nabzdyk C, Reiser J, Alt E. Geneti-cally selected stem cells from human adipose tissue express cardiacmarkers. Biochem Biophys Res Commun 2007; 353: 665-71.
7. Fraser JK, Schreiber R, Strem B, et al. Plasticity of human adiposestem cells toward endothelial cells and cardiomyocytes. Nat Clin-Pract Cardiovasc Med 2006; 3 (Suppl 1): S33-S37.
8. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an un-derappreciated source of stem cells for biotechnology. Trends Bio-technol 2006; 24: 150-4.
9. Strem BM, Zhu M, Alfonso Z, et al. Expression of cardiomyocyticmarkers on adipose tissue-derived cells in a murine model of acutemyocardial injury. Cytotherapy 2005; 7: 282-91.
10. Strem BM, Jordan MC, Kim JK, et al. Adipose tissue-derived stemcells enhance cardiac function following surgically-induced myo-cardial infarction. Circulation 2005; 112: U330-U330.
11. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bou-loumie A. Improvement of postnatal neovascularization by humanadipose tissue-derived stem cells. Circulation 2004; 110: 349-55.
12. Morizono K, De Ugarte DA, Zhu M, et al. Multilineage cells fromadipose tissue as gene delivery vehicles. Hum Gene Ther 2003; 14:59-66.
13. Peterson B, Zhang J, Iglesias R, et al. Healing of critically sizedfemoral defects, using genetically modified mesenchymal stemcells from human adipose tissue. Tissue Eng 2005; 11: 120-9.
14. Fraser JK, Schreiber RE, Zuk PA, Hedrick MH. Adult stem celltherapy for the heart. Int J Biochem Cell Biol 2004; 36: 658-66.
15. Zhu Y, Liu T, Song K, Ning R, Ma X, Cui Z. ADSCs differentiatedinto cardiomyocytes in cardiac microenvironment. Mol Cell Bio-chem 2009; 324: 117-29.
16. Yamada Y, Wang XD, Yokoyama S, Fukuda N, Takakura N. Car-diac progenitor cells in brown adipose tissue repaired damagedmyocardium. Biochem Biophys Res Commun 2006; 342: 662-70.
17. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesen-chymal stem cells repair scarred myocardium after myocardial in-farction. Nat Med 2006; 12: 459-65.
18. Planat-Benard V, Menard C, Andre M, et al. Spontaneous cardio-myocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94: 223-9.
19. Palpant NJ, Yasuda S-i, MacDougald O, Metzger JM. Non-canonical Wnt signaling enhances differentiation of Sca1+/c-kit+adipose-derived murine stromal vascular cells into spontaneouslybeating cardiac myocytes. J Mol Cell Cardiol 2007; 43: 362-70.
20. Ford ES. Risks for all-cause mortality, cardiovascular disease, anddiabetes associated with the metabolic syndrome: a summary of theevidence. Diabetes Care 2005; 28: 1769-78.
21. Ford ES. The metabolic syndrome and mortality from cardiovascu-lar disease and all-causes: findings from the National Health andNutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309-14.
22. Ford ES, Li C. Metabolic syndrome and health-related quality oflife among U.S. adults. Ann Epidemiol 2008; 18: 165-71.
23. Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C, for the Conference P. Definition of Metabolic Syndrome: Report ofthe National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition.Circulation 2004; 109: 433-8.
24. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syn-drome among US adults: findings from the third National Healthand Nutrition Examination Survey. JAMA 2002; 287: 356-9.
25. Thom T, Haase N, Rosamond W, et al. Heart disease and strokestatistics--2006 update: a report from the American Heart Associa-tion Statistics Committee and Stroke Statistics Subcommittee. Cir-culation 2006; 113: e85-151.
26. Fonarow GC. Heart failure: recent advances in prevention andtreatment. Rev Cardiovasc Med 2000; 1: 25-33, 54.
27. Schinkel AFL, Poldermans D, Rizzello V, et al. Why do patientswith ischemic cardiomyopathy and a substantial amount of viablemyocardium not always recover in function after revascularization?J Thorac Cardiovasc Surg 2004; 127: 385-90.
28. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cellsfrom adult myocardium: Homing, differentiation, and fusion afterinfarction. Proc Natl Acad Sci USA 2003; 100: 12313-8.
29. Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+cardioblastsenter fully differentiated cardiomyocyte lineages. Nature 2005;433: 647-53.
30. Muller P, Pfeiffer P, Koglin J, et al. Cardiomyocytes of noncardiacorigin in myocardial biopsies of human transplanted hearts. Circu-lation 2002; 106: 31-5.
31. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the trans-planted heart. N Engl J Med 2002; 346: 5-15.
32. Thiele J, Varus E, Wickenhauser C, et al. Mixed chimerism ofcardiomyocytes and vessels after allogeneic bone marrow andstem-cell transplantation in comparison with cardiac allografts.Transplantation 2004; 77: 1902-5.
33. MacLellan WR, Schneider MD. Genetic dissection of cardiacgrowth control pathways. Annu Rev Physiol 2000; 62: 289-319.
34. Becker AJ, Mc CE, Till JE. Cytological demonstration of the clonalnature of spleen colonies derived from transplanted mouse marrowcells. Nature 1963; 197: 452-4.
35. Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regen-eration. J Am Coll Cardiol 2004; 44: 464-6.
36. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: thescientific foundations of cardiac repair. J Clin Invest 2005; 115:572-583.
37. Orlic D. The strength of plasticity: stem cells for cardiac repair. IntJ Cardiol 2004; 95: S16-S19.
38. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration.Circ Res 2002; 91: 1092-102.
39. Nardi NB. All the adult stem cells, where do they all come from?An external source for organ-specific stem cell pools. Med Hy-potheses 2005; 64: 811-7.
40. Bick-Forrester J, Lee MS, Makkar RR, Forrester JS. Partial restora-tion of myocardial function and perfusion by cell therapy followingmyocardial infarction. Curr Opin Cardiol 2004; 19: 631-7.
41. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can begenerated from marrow stromal cells in vitro. J Clin Invest 1999;103: 697-705.
42. Schachinger V, Assmus B, Britten MB, et al. Transplantation ofprogenitor cells and regeneration enhancement in acute myocardialinfarction - Final one-year results of the TOPCARE-AMI trial. JAm Coll Cardiol 2004; 44: 1690-9.
43. Schachinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrow-derived progenitor cell therapy in need of proof of concept: designof the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1): S23-S28.
44. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P,Breidenbach C, et al. Intracoronary autologous bone-marrow celltransfer after myocardial infarction: the BOOST randomised con-trolled clinical trial. Lancet 2004; 364: 141-8.
45. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derivedhematopoietic cells generate cardiomyocytes at a low frequencythrough cell fusion, but not transdifferentiation. Nat Med 2004; 10:494-501.
46. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchy-mal stem cells can be mobilized and differentiate into cardiomyo-cytes after myocardial infarction. Blood 2004; 104: 3581-7.
47. Pittenger MF, Martin BJ. Mesenchymal stem cells and their poten-tial as cardiac therapeutics. Circ Res 2004; 95: 9-20.
48. Yoshioka T, Ageyama N, Shibata H, et al. Repair of infarctedmyocardium mediated by transplanted bone marrow-derivedCD34+ stem cells in a nonhuman primate model. Stem Cells 2005;23: 355-64.
49. Menasche P. Skeletal myoblast for cell therapy. Coron Artery Dis 2005; 16: 105-110.
50. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletalmyoblast transplantation for severe postinfarction left ventriculardysfunction. J Am Coll Cardiol 2003; 41: 1078-83.
51. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cellsare multipotent and support myocardial regeneration. Cell 2003;114: 763-76.
52. Kehat I, Gepstein L. Human embryonic stem cells for myocardialregeneration. Heart Fail Rev 2003; 8: 229-36.
53. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonicstem cells can differentiate into myocytes with structural and func-tional properties of cardiomyocytes. J Clin Invest 2001; 108: 407-14.
54. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integra-tion of cardiomyocytes derived from human embryonic stem cells.Nat Biotechnol 2004; 22: 1282-9.
55. Min JY, Yang YK, Sullivan MF, et al. Long-term improvement ofcardiac function in rats after infarction by transplantation of em-bryonic stem cells. J Thorac Cardiovasc Surg 2003; 125: 361-9.
56. Yamada Y, Yokoyama Si, Wang XD, Fukuda N, Takakura N. Cardiac stem cells in brown adipose tissue express CD133 and in-duce bone marrow nonhematopoietic cells to differentiate into car-diomyocytes. Stem Cells 2007; 25: 1326-33.
57. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T,Kaneda Y. Adipose tissue-derived stromal cells as a novel optionfor regenerative cell therapy. J Atheroscler Thromb 2006; 13: 77-81.
58. Chu K, Kim M, Chae SH, et al. Distribution and in situ prolifera-tion patterns of intravenously injected immortalized human neuralstem-like cells in rats with focal cerebral ischemia. Neurosci Res 2004; 50: 459-65.
59. Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hema-topoietic stem cells or G-CSF per se accelerate recovery and im-prove survival after liver injury, predominantly by promoting en-dogenous repair programs. Exp Hematol 2005; 33: 108-19.
60. Cannon RO. Cardiovascular potential of BM-derived stem andprogenitor cells. Cytotherapy 2004; 6: 602-7.
61. Hakelien AM, Collas P. Novel approaches to transdifferentiation.Cloning Stem Cells 2002; 4: 379-87.
62. Dimmeler S, Tjwa M. Better regenerative output after cellularinput: healing hearts by combining basic fibroblast factor and cell-based therapy. J Am Coll Cardiol 2008; 52: 1866-8.
63. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bonemarrow mononuclear cells into ischemic myocardium enhancescollateral perfusion and regional function via side supply of an-gioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104:1046-52.
64. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration inischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
65. Guo J, Lin GS, Bao CY, Hu ZM, Hu MY. Anti-inflammation rolefor mesenchymal stem cells transplantation in myocardial infarc-tion. Inflammation 2007; 30: 97-104.
66. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stemcells do not transdifferentiate into cardiac myocytes in myocardialinfarcts. Nature 2004; 428: 664-8.
67. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cellsrepair the infarcted heart, improving function and survival. ProcNatl Acad Sci USA 2001; 98: 10344-9.
68. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regener-ate infarcted myocardium. Nature 2001; 410: 701-5.
69. van der Bogt KE, Schrepfer S, Yu J, et al. Comparison of trans-plantation of adipose tissue- and bone marrow-derived mesenchy-mal stem cells in the infarcted heart. Transplantation 2009; 87:642-52.
70. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection ofmononuclear bone marrow cells in acute myocardial infarction. NEngl J Med 2006; 355: 1199-209.
71. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005; 23: 845-56.
72. Gaustad KG, Boquest AC, Anderson BE, Gerdes AM, Collas P.Differentiation of human adipose tissue stem cells using extracts ofrat cardiomyocytes. Biochem Biophys Res Commun 2004; 314:420-7.
73. van Dijk A, Niessen HW, Zandieh Doulabi B, Visser FC, van Mil-ligen FJ. Differentiation of human adipose-derived stem cells to-wards cardiomyocytes is facilitated by laminin. Cell Tissue Res 2008; 334: 457-67.
74. Madonna R, Willerson JT, Geng YJ. Myocardin a enhances telom-erase activities in adipose tissue mesenchymal cells and embryonicstem cells undergoing cardiovascular myogenic differentiation.Stem Cells 2008; 26: 202-11.
75. Song YH, Gehmert S, Sadat S, et al. VEGF is critical for spontane-ous differentiation of stem cells into cardiomyocytes. BiochemBiophys Res Commun 2007; 354: 999-1003.
76. Nakamura T, Sano M, Songyang Z, Schneider MD. A Wnt- andbeta-catenin-dependent pathway for mammalian cardiac myogene-sis. Proc Natl Acad Sci USA 2003; 100: 5834-9.
77. Pandur P, Lasche M, Eisenberg LM, Kuhl M. Wnt-11 activation ofa non-canonical Wnt signalling pathway is required for cardiogene-sis. Nature 2002; 418: 636-41.
78. Terami H, Hidaka K, Katsumata T, Iio A, Morisaki T. Wnt11 fa-cilitates embryonic stem cell differentiation to Nkx2.5-positive car-diomyocytes. Biochem Biophys Res Commun 2004; 325: 968-75.
79. Koyanagi M, Haendeler J, Badorff C, et al. Non-canonical Wntsignaling enhances differentiation of human circulating progenitorcells to cardiomyogenic cells. J Biol Chem 2005; 280: 16838-42.
80. Foley AC, Mercola M. Heart induction by Wnt antagonists dependson the homeodomain transcription factor Hex. Genes Dev 2005;19: 387-96.
81. Brand T. Heart development: molecular insights into cardiac speci-fication and early morphogenesis. Dev Biol 2003; 258: 1-19.
82. Minasi MG, Riminucci M, De Angelis L, et al. The meso-angioblast: a multipotent, self-renewing cell that originates fromthe dorsal aorta and differentiates into most mesodermal tissues.Development 2002; 129: 2773-84.
83. Galli D, Innocenzi A, Staszewsky L, et al. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by mul-tiple cellular mechanisms - A comparison with bone marrow pro-genitors, fibroblasts, and endothelial cells. Arterioscler ThrombVasc Biol 2005; 25: 692-7.
84. Urbanek K, Sheikh F, Silvestri F, et al. Cardiac stem cells inischemic heart failure. J Mol Cell Cardiol 2005; 38: 851.
85. Kim Y, Kim H, Cho H, Bae Y, Suh K, Jung J. Direct comparisonof human mesenchymal stem cells derived from adipose tissues andbone marrow in mediating neovascularization in response to vascu-lar ischemia. Cell Physiol Biochem 2007; 20: 867-76.
86. Rehman J, Traktuev D, Li JL, et al. Secretion of angiogenic andantiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-8.
87. Sadat S, Gehmert S, Song YH, et al. The cardioprotective effect ofmesenchymal stem cells is mediated by IGF-I and VEGF. BiochemBiophys Res Commun 2007; 363: 674-9.
88. Yamada Y, Yokoyama S, Fukuda N, et al. A novel approach formyocardial regeneration with educated cord blood cells coculturedwith cells from brown adipose tissue. Biochem Biophys ResCommun 2007; 353: 182-8.
89. Schenke-Layland K, Strem BM, Jordan MC, et al. Adipose tissue-derived cells improve cardiac function following myocardial in-farction. J Surg Res 2009; 153(2): 217-23.
90. Cai L, Johnstone BH, Cook TG, et al. IFATS series: human adi-pose tissue-derived stem cells induce angiogenesis and nervesprouting following myocardial infarction, in conjunction with po-tent preservation of cardiac function. Stem Cells 2009; 27(1): 230-7.
91. Zhu XY, Zhang XZ, Xu L, Zhong XY, Ding Q, Chen YX. Trans-plantation of adipose-derived stem cells overexpressing hHGF intocardiac tissue. Biochem Biophys Res Commun 2009; 379: 1084-90.
92. Valina C, Pinkernell K, Song YH, et al. Intracoronary administra-tion of autologous adipose tissue-derived stem cells improves leftventricular function, perfusion, and remodelling after acute myo-cardial infarction. Eur Heart J 2007; 28: 2667-77.
93. Mazo M, Planat-Benard V, Abizanda G, et al. Transplantation ofadipose derived stromal cells is associated with functional im-provement in a rat model of chronic myocardial infarction. Eur JHeart Fail 2008; 10: 454-62.
94. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms inadult stem cell signaling and therapy. Circ Res 2008; 103: 1204-19.
95. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic media-tors. J Cell Biochem 2006; 98: 1076-84.
96. Makino H, Okada S, Nagumo A, et al. Decreased circulatingCD34+ cells are associated with progression of diabetic nephropa-thy. Diabet Med 2009; 26: 171-3.
97. Chen MC, Sheu JJ, Wang PW, et al. Complications impaired endo-thelial progenitor cell function in Type 2 diabetic patients with orwithout critical leg ischaemia: implication for impaired neovascu-larization in diabetes. Diabet Med 2009; 26: 134-41.
98. Zhang H, Park Y, Wu J, et al. Role of TNF-alpha in vascular dys-function. Clin Sci (Lond) 2009; 116: 219-230.
99. Ohshima M, Li TS, Kubo M, Qin SL, Hamano K. Antioxidanttherapy attenuates diabetes-related impairment of bone marrowstem cells. Circ J 2009; 73: 162-6.
100. Urbich C, Dernbach E, Rossig L, Zeiher AM, Dimmeler S. Highglucose reduces cathepsin L activity and impairs invasion of circu-lating progenitor cells. J Mol Cell Cardiol 2008; 45: 429-436.
101. Voo S, Dunaeva M, Eggermann J, Stadler N, Waltenberger J. Dia-betes mellitus impairs CD133+ progenitor cell function after myo-cardial infarction. J Intern Med 2009; 265: 238-249.
102. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derivedcells. Cell Transplant 2007; 16: 963-970.
103. Reinecke H, Minami E, Zhu WZ, Laflamme MA. Cardiogenicdifferentiation and transdifferentiation of progenitor cells. Circ Res 2008; 103: 1058-1071.
104. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL,Robbins RC. Haematopoietic stem cells adopt mature haema-topoietic fates in ischaemic myocardium. Nature 2004; 428: 668-673.
105. Chien KR. Stem cells: lost in translation. Nature 2004; 428: 607-608.
106. Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stemcell transplantation in postinfarcted rat myocardium: short- andlong-term effects. Circulation 2005; 112: 214-23.
107. Kicic A, Shen WY, Wilson AS, Constable IJ, Robertson T, Ra-koczy PE. Differentiation of marrow stromal cells into photorecep-tors in the rat eye. J Neurosci 2003; 23: 7742-9.
108. Davani S, Marandin A, Mersin N, et al. Mesenchymal progenitorcells differentiate into an endothelial phenotype, enhance vasculardensity, and improve heart function in a rat cellular cardiomyo-plasty model. Circulation 2003; 108 (Suppl 1): II253-258.
109. Leiker M, Suzuki G, Iyer VS, Canty JM, Jr., Lee T. Assessment ofa nuclear affinity labeling method for tracking implanted mesen-chymal stem cells. Cell Transplant 2008; 17: 911-22.
110. Leo BM, Li X, Balian G, Anderson DG. In vivo bioluminescentimaging of virus-mediated gene transfer and transduced cell trans-plantation in the intervertebral disc. Spine 2004; 29: 838-44.
111. Dragoo JL, Choi JY, Lieberman JR, et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 2003; 21: 622-9.
112. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Im-provement of neurological deficits by intracerebral transplantationof human adipose tissue-derived stromal cells after cerebral ische-mia in rats. Exp Neurol 2003; 183: 355-66.
113. Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrinehypothesis for Akt-modified mesenchymal stem cell-mediated car-diac protection and functional improvement. FASEB J 2006; 20:661-9.
114. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M. Exvivo delivered stromal cell-derived factor-1alpha promotes stemcell homing and induces angiomyogenesis in the infarcted myocar-dium. J Mol Cell Cardiol 2007; 42: 792-803.
115. Novak A, Guo CY, Yang WY, Nagy A, Lobe CG. Z/EG, a doublereporter mouse line that expresses enhanced green fluorescent pro-tein upon Cre-mediated excision. Genesis 2000; 28: 147-55.
116. Hsieh PC, Segers VF, Davis ME, et al. Evidence from a geneticfate-mapping study that stem cells refresh adult mammalian car-diomyocytes after injury. Nat Med 2007; 13: 970-974.
117. Andrade J, Lam JT, Zamora M, et al. Predominant fusion of bonemarrow-derived cardiomyocytes. Cardiovasc Res 2005; 68: 387-93.
118. Ruiz-Lozano P, Chien KR. Cre-constructing the heart. Nat Genet 2003; 33: 8-9.
119. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C,Rodriguez-Montes JA. A phase I clinical trial of the treatment ofCrohn's fistula by adipose mesenchymal stem cell transplantation.Dis Colon Rectum 2005; 48: 1416-23.
120. Turner I, Belema-Bedada F, Martindale J, et al. Molecular Cardiol-ogy in Translation: Gene, Cell and Chemical-Based ExperimentalTherapeutics for the Failing Heart. J Cardiovasc Transl Res 2008;1: 317-27.